Cyrollah Disoma
-
- MicroRNA in disease regulation 2
-
- RNA modifications and cancer 2
- Circular RNAs in diseases 2
-
- SARS-CoV-2 and COVID-19 Research 2
- COVID-19 Clinical Research Studies 2
-
- Cancer Mechanisms and Therapy 2
-
- Aquatic Ecosystems and Biodiversity 1
-
- Lichen and fungal ecology 1
- Journals
- Biochemical and Biophysical Research Communications (1 paper)International Journal of Molecular Sciences (1 paper)Molecular Cancer (1 paper)
- Partner nations
- ChinaPhilippinesItaly
In The Last Decade
Cyrollah Disoma
11 papers receiving 267 citations
Hit Papers
Peers
Comparison fields: 5 of 63
- Cancer Research 137
- Molecular Biology 216
- Oncology 28
- Infectious Diseases 18
- Toxicology 3
Countries citing papers authored by Cyrollah Disoma
This map shows the geographic impact of Cyrollah Disoma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cyrollah Disoma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cyrollah Disoma more than expected).
Fields of papers citing papers by Cyrollah Disoma
This network shows the impact of papers produced by Cyrollah Disoma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cyrollah Disoma. The network helps show where Cyrollah Disoma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cyrollah Disoma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 49 | |
| 6 | 2022 | 12 | |
| 7 | M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinomabreakdown → | 2022 | 145 |
| 8 | 2022 | 1 | |
| 9 | 2021 | 22 | |
| 10 | 2020 | 19 | |
| 11 | 2020 | 1 | |
| 12 | 2019 | 14 | |
| 13 | 2018 | 2 |
About Cyrollah Disoma
Cyrollah Disoma is a scholar working on Periodontics, Cancer Research and Hepatology, having authored 13 papers that have together received 269 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (2 papers), Cancer Mechanisms and Therapy (2 papers), COVID-19 Clinical Research Studies (2 papers), MicroRNA in disease regulation (2 papers), RNA modifications and cancer (2 papers), Circular RNAs in diseases (2 papers), Aquatic Ecosystems and Biodiversity (1 paper) and Lichen and fungal ecology (1 paper). The work is most often cited by research in Cancer Research (137 citations), Molecular Biology (216 citations) and Oncology (28 citations). Cyrollah Disoma has collaborated with scholars based in China, Philippines and Italy. Frequent co-authors include Yuzheng Zhou, Zanxian Xia, Shanni Li, Jian Peng, Aroona Razzaq, Zijun Dong, Ashuai Du, Shiqin Li, Pinjia Liu and Zongpeng Chen. Their work appears in journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.